A prospective analysis of clinical variables, serologic factors, and outcome of ileal pouch-anal anastomosis in patients with backwash ileitis

Diseases of the Colon and Rectum

Volumn 53, Issue 7, 2010, Pages 987-994

  White, Evan ^a   Melmed, Gil Y ^a   Vasiliauskas, Eric A ^a   Dubinsky, Marla ^a   Berel, Dror ^a   Targan, Stephan R ^a   Fleshner, Phillip R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Backwash ileitis; Ileal pouch anal anastomosis; Indeterminate colitis; Inflammatory bowel disease unclassified; Pouchitis; Serologic factors; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CHILD; CLINICAL FEATURE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FISTULA; FOLLOW UP; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SCHOOL CHILD; SEROLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANAL CANAL; ANASTOMOSIS, SURGICAL; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHILD; COLONIC POUCHES; COLONOSCOPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILEITIS; ILEUM; INCIDENCE; MALE; MIDDLE AGED; POUCHITIS; PROGNOSIS; PROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 77954404835     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181dcb3f2     Document Type: Article

References (26)

1. FazioVW,Ziv Y, Church JM, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg. 1995; 222:120-127.
2. Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and longterm outcome in 1310 patients. Br J Surg. 1998;85:800-803.
3. Coffey JC, Winter DC, Neary P, Murphy A, Redmond HP, Kirwan WO. Quality of life after ileal pouch-anal anastomosis: an evaluation of diet and other factors using the Cleveland Global Quality of Life instrument. Dis Colon Rectum. 2002;45:30-38.
4. Shen B, Fazio VW, Remzi FH, et al. Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouchanal anastomosis. Am J Gastroenterol. 2005;100:93-101.
5. Saltzstein SL, Rosenberg BF. Ulcerative colitis of the ileum, and regional enteritis of the colon: a comparative histopathologic study. Am J Clin Pathol. 1963;40:610-623.
6. Schmidt CM, Lazenby AJ, Hendrickson RJ, Sitzmann JV. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg. 1998;227:654-665.
7. Abdelrazeq AS, Wilson TR, Leitch DL, Lund JN, Leveson SH. Ileitis in ulcerative colitis: is it a backwash? Dis Colon Rectum. 2005;48:2038-2046.
8. Ferrante M, Declerk S, deHertogh G, et al. Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis. 2008;14:20-28.
9. Gustavsson S, Weiland LH, Kelly KA. Relationship of backwash ileitis to ileal pouchitis after ileal pouch-anal anastomosis. Dis Colon Rectum. 1987;30:25-28.
10. Haskell H, Andrews Jr. CW, Sarathchandra I, et al. Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis. Am J Surg Pathol. 2005;29:1472-1481.
11. Fleshner PR, Ippoliti A, Dubinsky MC, et al. A prospective multivariate analysis of perioperative clinical factors associated with acute or chronic pouchitis after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol. 2007;5:952-958.
12. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can. J. Gastroenterol. 2005;19(suppl A):5-36.
13. Munoz-Juarez M, Pemberton JH, Sandborn WJ, Tremaine WJ, Dozois RR. Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis. Dis Colon Rectum. 1999;42:117-120.
14. Wolf JM, Achkar JP, Lashner BA, et al. Afferent limb ulcers predict Crohn's disease in patients with ileal pouch-anal anastomosis. Gastroenterology. 2004;126:1686-1691.
15. Shen B, Fazio VW, Remzi FH, et al. Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouchanal anastomosis. Am J Gastroenterol. 2005;100:93-101.
16. Targan SR, Landers CJ, Yang H, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology. 2005;128: 2020-2028.
17. MowWS, Vasiliauskas EA, Lin YC, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology. 2004;126:414-424.
18. Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002;123(3): 689-699.
19. Fleshner PR, Vasiliauskas EA, Kam LY, et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut. 2001;49:671-677.
20. Goldstein NS, Dulai M. Contemporary morphologic definition of backwash ileitis in ulcerative colitis and features that distinguish it from Crohn's disease.AmJ Clin Path. 2006;126:365-376
21. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc. 1994;69:409-415.
22. Shen B, Achkar JP, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology. 2001;121:261-267.
23. Hueschen UA, Hinz U, Allemeyer EH, et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology. 2001;120:841-847.
24. Loftus EV Jr, Harewood GC, Loftus CG, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91-96.
25. Balan V, LaRusso NF. Hepatobiliary disease in inflammatory bowel disease. Gastroenterol Clin North Am. 1995;24:647-667.
26. Seibold F, Brandwein S, Simpson S, Terhorst C, Elson CO. pANCA represents a cross-reactivity to enteric bacterial antigens. J Clin Immunol. 1998;18:153-158.